Arch Venture Management’s Prime Medicine PRME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$56.5M Buy
+18,486,894
New +$61.4M 3.5% 12

Other funds holding PRME

Arch Venture Management's PRME Position: Q3 2026 in Review

Arch Venture Management opened a new position in Prime Medicine (PRME) in Q3 2026: 18,486,894 shares worth $56.5M. The stake represents 3.5% of the portfolio and ranks #12 among its holdings.

181 funds tracked by Wall St. Rank hold PRME as of Q3 2026.

  • Arch Venture Management held 18,486,894 shares of Prime Medicine worth $56.5M as of Q3 2026.
  • Prime Medicine was a new Arch Venture Management position in Q3 2026.
  • Prime Medicine made up 3.5% of Arch Venture Management's portfolio in Q3 2026, its #12 holding.
  • 181 funds tracked by Wall St. Rank held Prime Medicine as of Q3 2026.

Based on Arch Venture Management's 13F filing for Q3 2026, filed 16 Nov 2026.